Narrow search
Showing 1 - 10 of 16,983
Cover Image
Affordability of drugs in developing countries
Caldera, Aida; Zarnic, Ziga - 2004
Persistent link: https://www.econbiz.de/10002157826
Cover Image
Organizational scope and investment : evidence from the drug development strategies and performance of biopharmaceutical firms
Guedj, Ilan; Scharfstein, David - 2004
Persistent link: https://www.econbiz.de/10002481759
Cover Image
Pharmaceutical embodied technical progress, longevity, and quality of life : drugs as "equipment for your health"
Lichtenberg, Frank R.; Virabhak, Suchin - 2002
Persistent link: https://www.econbiz.de/10001719206
Cover Image
Does medicaid pay too much for precscription drugs? : A case study of atypical anti-psychotics
Duggan, Mark G. - 2003
Persistent link: https://www.econbiz.de/10001753201
Cover Image
The economics of pharmaceutical industry
Reekie, W. Duncan - 1975
Persistent link: https://www.econbiz.de/10013485280
Cover Image
Generikasubstitution und Arzneimittelwettbewerb : eine empirische Untersuchung der Preis- und Verordnungsdeterminanten
Homann, Markus - 2000
Persistent link: https://www.econbiz.de/10001461290
Cover Image
Relationship Marketing in der Pharmazeutischen Industrie : Vertrauen und Commitment als Erfolgsfaktoren
Witzel, Rüdiger - 2006 - 1. Aufl.
Persistent link: https://www.econbiz.de/10013515298
Cover Image
Pharmaceutical prices: the impact of the launch strategy : an analysis of German data
Böhler, Yvonne-Beatrice; Lamping, Christian; Wichardt, … - 2019
This paper reports the results from a statistical analysis of pharmaceutical price negotiations in Germany, where the … pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …
Persistent link: https://www.econbiz.de/10012103333
Cover Image
Pharmaceutical prices : the impact of the launch strategy - an analysis of German data
Böhler, Yvonne-Beatrice; Lamping, Christian; Wichardt, … - 2019 - This Version: September 24, 2019
This paper reports the results from a statistical analysis of pharmaceutical price negotiations in Germany, where the … pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …
Persistent link: https://www.econbiz.de/10012119750
Cover Image
The effects of reference pricing on ex-factory prices of Rx drugs in Germany : a panel data approach
Augurzky, Boris; Göhlmann, Silja; Greß, Stefan; … - 2006
This paper examines effects of reference pricing for prescription drugs in German social health insurance based on econometric panel data methods. We analyze the effect on ex-factory prices. Moreover, we investigate whether manufacturers adapt prices of their products not subject to reference...
Persistent link: https://www.econbiz.de/10003358966